← All indications
Hypotension, Orthostatic
A significant drop in BLOOD PRESSURE after assuming a standing position. Orthostatic hypotension is a finding, and defined as a 20-mm Hg decrease in systolic pressure or a 10-mm Hg decrease in diastolic pressure 3 minutes after the person has risen from supine to standing. Symptoms generally include DIZZINESS, blurred vision, and SYNCOPE.
Drugs by status
Phase 3 trials (7)
Phase 2 trials (3)
Phase 1 trials (31)
- melatonin
- phenylephrine
- acetazolamide
- bovril
- diphenhydramine
- methylphenidate
- ibuprofen
- fludrocortisone
- acarbose
- nitroprusside
- octreotide
- indomethacin
- caffeine
- propranolol
- rivastigmine
- celecoxib
- clonidine
- tranylcypromine
- trimethaphan
- atropine
- domperidone
- modafinil
- tension
- yohimbine
- ergotamine
- pseudoephedrine
- oxymetazoline
- isoprenaline
- ranitidine
- tyramine
- +1 more
Other trials (4)
Organizations
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (17)
- Theravance
- TSH Biopharm Corporation Limited
- University of London
- Harvard University
- New York University
- University of Kansas
- University of South Florida
- Mayo Clinic
- Taipei Medical University
- University of Copenhagen
- Vanderbilt University
- University of Toulouse
- Arkansas Cardiology
- North Alabama Neuroscience
- Bradenton Neurology, Inc
- Chiltern International
- Suncoast Clinical Research
Organization Involved with Phase 2 Indications (8)
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (3)